Skip to content

Author

S. Duhamel

6 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

A Visual LGE Extent Cutoff for Mortality Risk Stratification in Ischemic Cardiomyopathy.

BACKGROUND Late gadolinium enhancement (LGE) extent has been linked to adverse outcomes in ischemic cardiomyopathy (ICM). While quantitative methods of LGE assessment are widely accepted, semi-quantitative methods remain debated but still hold value. This study aimed to determine an optimal LGE segments cutoff for ICM...

Alexandre Unger, J. Garot, S. Duhamel et al. · 0 citations
Open access Oct 2026

Sex-related differences of late gadolinium enhancement granularity in hypertrophic cardiomyopathy: a cardiovascular magnetic resonance study

Although prognosis in hypertrophic cardiomyopathy (HCM) differs between women and men, sex-related differences regarding cardiovascular magnetic resonance (CMR) features, especially late gadolinium enhancement (LGE), remains poorly studied. To assess the sex-related prognostic value of the “LGE granularity...

F. Abadie, J. Florence, Y. Bohbot et al. · 0 citations
Open access Oct 2026

Prognostic Value of Late Gadolinium Enhancement Findings in Isolated Left Ventricular Dilatation and Dilated Cardiomyopathy.

LGE findings were strongly and independently associated with death in both ILVD and DCM patients, with each successive LGE characteristic providing significant incremental prognostic value beyond traditional prognosticators, including LVEF.

Trecy Gonçalves, S. Duhamel, Solenn Toupin et al. · 0 citations
Open access Oct 2026

Clinical implications of late gadolinium enhancement in patients with active cancer undergoing stress CMR

Cardiovascular disease and cancer are the two leading causes of mortality worldwide. (1) Advances in oncologic therapies have improved cancer survival, resulting in a growing population of patients with active malignancy or cancer survivors who remain at increased risk of cardiovascular and non-cancer mortality....

A. Afana, S. Duhamel, S. Toupin et al. · 0 citations
Open access Sep 2026

Vasodilator stress perfusion CMR for outcome prediction in patients under 45 years with suspected CAD.

BACKGROUND Although the prognostic value of vasodilator stress cardiovascular magnetic resonance (CMR) is established, it has never been assessed in patients <45 years with suspected coronary artery disease. The aim was to assess the long-term prognostic value of stress CMR to predict mortality in a multicenter cohort...

Elsa Richard de Vesvrotte, J. Garot, S. Duhamel et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.